# SymBiosis Capital Management

SymBiosis Capital Management is a Private Equity based in Bentonville, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Bentonville, United States
- **Region:** North America
- **Address:** Bentonville, AR, United States
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** symbiosis.vc

## Regulatory record

- **Reports private funds:** No

## About

SymBiosis Capital Management is a biotechnology VC firm in Arkansas. The firm is investing in a future where bioengineering has industrial scale and speed, and today’s barely conceivable medicines are routine. It partners with innovators building groundbreaking companies focused on life-threatening disease with hard endpoints, novel therapeutic platforms in any modality, leads reaching human proof-of-concept, and designs for manufacturability.

## Sectors

- Venture (General)
- Early Stage
- Expansion / Late Stage

## People

- Chidozie Ugwumba — Managing Partner
- Chidozie Ugwumba — Managing Partner
- Aleksei Cremo — Principal, Investments
- Allie Ivy — PhD, Associate, Investments
- Aryan Vora — Associate, Investments
- Brendon Dobbs — Vice President, AI & Analytics
- Caleb Kreutner — Senior Vice President, Finance & Operations
- Catherine Shoults — PhD, Senior Vice President, AI & Analytics
- Geraldine Schott — PhD, Vice President, Investments
- Trevor Goethe — Associate, Finance & Operations
- Christopher McDonald — Operating Advisor
- Gbola Amusa — MD, CFA, Operating Advisor
- Gene Kym — PhD, Operating Advisor
- Jennifer Miller — PhD, Operating Advisor
- Sandy Zweifach — Operating Advisor
- Ramona Mullen — Senior Executive Assistant
- Sarah Hernandez — Senior Executive Assistant

## Questions

### Who runs investment decisions at SymBiosis Capital Management?

Principal leadership has not been publicly identified in available records or the firm's digital footprint as of 2026. SymBiosis operates with a low public profile, and no named investment committee members or managing partners have been confirmed through the firm's official communications or regulatory filings. This is common among regionally concentrated firms that source through relationship networks rather than marketed brand visibility.

### What investment stages does SymBiosis typically target?

The firm invests across seed, early-stage, start-up, and expansion or late-stage venture rounds. This stage-flexible mandate allows SymBiosis to write initial institutional checks and to follow those commitments into subsequent growth financings. No stage-specific fund vehicle separation has been publicly documented.

### Which sectors does SymBiosis explicitly avoid?

No negative sector screening or explicit exclusion list has been published. As a generalist venture investor operating from a non-coastal geography, the firm is unlikely to compete in capital-intensive deep-tech verticals that are tightly clustered around national-lab ecosystems. The firm's investment pattern is expected to follow the economic profile of its regional base—skewing toward applied technology in supply chain, commerce, and industrial workflows—rather than life sciences or frontier hardware.

## Related profiles

- [SymbiaVC](https://altss.com/profile/symbiavc)
- [Symbol](https://altss.com/profile/symbol)

---

Last updated: 2026-08-11T15:08:18.003Z

Canonical page: https://altss.com/profile/symbiosis-capital-management

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology